Genetics of melanocytic nevi

MiRyung Roh, Philip Eliades, Sameer Gupta, Hensin Tsao

Research output: Contribution to journalReview article

48 Citations (Scopus)

Abstract

Melanocytic nevi are a benign clonal proliferation of cells expressing the melanocytic phenotype, with heterogeneous clinical and molecular characteristics. In this review, we discuss the genetics of nevi by salient nevi subtypes: congenital melanocytic nevi, acquired melanocytic nevi, blue nevi, and Spitz nevi. While the molecular etiology of nevi has been less thoroughly studied than melanoma, it is clear that nevi and melanoma share common driver mutations. Acquired melanocytic nevi harbor oncogenic mutations in BRAF, which is the predominant oncogene associated with melanoma. Congenital melanocytic nevi and blue nevi frequently harbor NRAS mutations and GNAQ mutations, respectively, while Spitz and atypical Spitz tumors often exhibit HRAS and kinase rearrangements. These initial 'driver' mutations are thought to trigger the establishment of benign nevi. After this initial phase of the cell proliferation, a senescence program is executed, causing termination of nevi growth. Only upon the emergence of additional tumorigenic alterations, which may provide an escape from oncogene-induced senescence, can malignant progression occur. Here, we review the current literature on the pathobiology and genetics of nevi in the hope that additional studies of nevi promise to inform our understanding of the transition from benign neoplasm to malignancy.

Original languageEnglish
Pages (from-to)661-672
Number of pages12
JournalPigment Cell and Melanoma Research
Volume28
Issue number6
DOIs
Publication statusPublished - 2015 Nov 1

Fingerprint

Pigmented Nevus
Nevus
Ports and harbors
Cell proliferation
Mutation
Tumors
Blue Nevus
Phosphotransferases
Cells
Oncogenes
Melanoma
Epithelioid and Spindle Cell Nevus
Cell Proliferation
Nevi and Melanomas
Neoplasms
Genetics
Phenotype
Growth

All Science Journal Classification (ASJC) codes

  • Oncology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Dermatology

Cite this

Roh, MiRyung ; Eliades, Philip ; Gupta, Sameer ; Tsao, Hensin. / Genetics of melanocytic nevi. In: Pigment Cell and Melanoma Research. 2015 ; Vol. 28, No. 6. pp. 661-672.
@article{cd1693a7cdc547d3baa3d15fabaa0518,
title = "Genetics of melanocytic nevi",
abstract = "Melanocytic nevi are a benign clonal proliferation of cells expressing the melanocytic phenotype, with heterogeneous clinical and molecular characteristics. In this review, we discuss the genetics of nevi by salient nevi subtypes: congenital melanocytic nevi, acquired melanocytic nevi, blue nevi, and Spitz nevi. While the molecular etiology of nevi has been less thoroughly studied than melanoma, it is clear that nevi and melanoma share common driver mutations. Acquired melanocytic nevi harbor oncogenic mutations in BRAF, which is the predominant oncogene associated with melanoma. Congenital melanocytic nevi and blue nevi frequently harbor NRAS mutations and GNAQ mutations, respectively, while Spitz and atypical Spitz tumors often exhibit HRAS and kinase rearrangements. These initial 'driver' mutations are thought to trigger the establishment of benign nevi. After this initial phase of the cell proliferation, a senescence program is executed, causing termination of nevi growth. Only upon the emergence of additional tumorigenic alterations, which may provide an escape from oncogene-induced senescence, can malignant progression occur. Here, we review the current literature on the pathobiology and genetics of nevi in the hope that additional studies of nevi promise to inform our understanding of the transition from benign neoplasm to malignancy.",
author = "MiRyung Roh and Philip Eliades and Sameer Gupta and Hensin Tsao",
year = "2015",
month = "11",
day = "1",
doi = "10.1111/pcmr.12412",
language = "English",
volume = "28",
pages = "661--672",
journal = "Pigment Cell and Melanoma Research",
issn = "1755-1471",
publisher = "Wiley-Blackwell",
number = "6",

}

Roh, M, Eliades, P, Gupta, S & Tsao, H 2015, 'Genetics of melanocytic nevi', Pigment Cell and Melanoma Research, vol. 28, no. 6, pp. 661-672. https://doi.org/10.1111/pcmr.12412

Genetics of melanocytic nevi. / Roh, MiRyung; Eliades, Philip; Gupta, Sameer; Tsao, Hensin.

In: Pigment Cell and Melanoma Research, Vol. 28, No. 6, 01.11.2015, p. 661-672.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Genetics of melanocytic nevi

AU - Roh, MiRyung

AU - Eliades, Philip

AU - Gupta, Sameer

AU - Tsao, Hensin

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Melanocytic nevi are a benign clonal proliferation of cells expressing the melanocytic phenotype, with heterogeneous clinical and molecular characteristics. In this review, we discuss the genetics of nevi by salient nevi subtypes: congenital melanocytic nevi, acquired melanocytic nevi, blue nevi, and Spitz nevi. While the molecular etiology of nevi has been less thoroughly studied than melanoma, it is clear that nevi and melanoma share common driver mutations. Acquired melanocytic nevi harbor oncogenic mutations in BRAF, which is the predominant oncogene associated with melanoma. Congenital melanocytic nevi and blue nevi frequently harbor NRAS mutations and GNAQ mutations, respectively, while Spitz and atypical Spitz tumors often exhibit HRAS and kinase rearrangements. These initial 'driver' mutations are thought to trigger the establishment of benign nevi. After this initial phase of the cell proliferation, a senescence program is executed, causing termination of nevi growth. Only upon the emergence of additional tumorigenic alterations, which may provide an escape from oncogene-induced senescence, can malignant progression occur. Here, we review the current literature on the pathobiology and genetics of nevi in the hope that additional studies of nevi promise to inform our understanding of the transition from benign neoplasm to malignancy.

AB - Melanocytic nevi are a benign clonal proliferation of cells expressing the melanocytic phenotype, with heterogeneous clinical and molecular characteristics. In this review, we discuss the genetics of nevi by salient nevi subtypes: congenital melanocytic nevi, acquired melanocytic nevi, blue nevi, and Spitz nevi. While the molecular etiology of nevi has been less thoroughly studied than melanoma, it is clear that nevi and melanoma share common driver mutations. Acquired melanocytic nevi harbor oncogenic mutations in BRAF, which is the predominant oncogene associated with melanoma. Congenital melanocytic nevi and blue nevi frequently harbor NRAS mutations and GNAQ mutations, respectively, while Spitz and atypical Spitz tumors often exhibit HRAS and kinase rearrangements. These initial 'driver' mutations are thought to trigger the establishment of benign nevi. After this initial phase of the cell proliferation, a senescence program is executed, causing termination of nevi growth. Only upon the emergence of additional tumorigenic alterations, which may provide an escape from oncogene-induced senescence, can malignant progression occur. Here, we review the current literature on the pathobiology and genetics of nevi in the hope that additional studies of nevi promise to inform our understanding of the transition from benign neoplasm to malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84944461022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944461022&partnerID=8YFLogxK

U2 - 10.1111/pcmr.12412

DO - 10.1111/pcmr.12412

M3 - Review article

C2 - 26300491

AN - SCOPUS:84944461022

VL - 28

SP - 661

EP - 672

JO - Pigment Cell and Melanoma Research

JF - Pigment Cell and Melanoma Research

SN - 1755-1471

IS - 6

ER -